In The News

In Washington Post, Health Care Partner Comments on State Legislation Targeting Drug Pricing Middleman

Practices: Health Care, Health Care Finance & Restructuring

A May 21 article in The Washington Post’s Health 202 column on prescription drug pricing includes remarks from health care partner Tom Bulleit (Washington, D.C.), describing several different strategies that state legislatures have been taking to provide more regulation of pharmacy benefit managers, key “middlemen” in the drug supply chain that President Trump has stated his administration plans to make less “rich” as part of its 4-point plan to reduce prescription drug prices.

Cookie Settings